💊 AI Designs Next-Generation Medicines
Biologics development is shifting from manual searching to autonomous closed-loop systems. AI enables the *de novo* design of drugs, optimizing their efficacy, stability, and safety.
🌍 The transition to automated protein design and multispecific molecules radically reduces risks and costs, turning the process into a manageable engineering task.
👤 This will accelerate the time-to-market for new treatments for complex diseases and usher in the era of "programmable" medicine.